United Arab Emirates: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the United Arab Emirates

The prophylactic medicaments containing insulin market in the United Arab Emirates rose modestly to $X in 2022, with an increase of 3% against the previous year. Over the period under review, consumption, however, enjoyed strong growth. Prophylactic medicaments containing insulin consumption peaked at $X in 2017; however, from 2018 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the United Arab Emirates

In value terms, prophylactic medicaments containing insulin production reached $X in 2022 estimated in export price. Overall, production, however, continues to indicate resilient growth. The most prominent rate of growth was recorded in 2014 with an increase of 46%. Prophylactic medicaments containing insulin production peaked at $X in 2017; however, from 2018 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from the United Arab Emirates

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from the United Arab Emirates; increasing by 450% on 2021. Overall, exports showed a significant expansion. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports rose markedly to $X in 2022. In general, exports showed a prominent increase. The pace of growth appeared the most rapid in 2017 when exports increased by 252%. Over the period under review, the exports reached the maximum at $X in 2020; however, from 2021 to 2022, the exports remained at a lower figure.

Exports by Country

Tunisia (X tons) was the main destination for prophylactic medicaments containing insulin exports from the United Arab Emirates, accounting for a approx. 100% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Tunisia totaled +98.5%.

In value terms, Tunisia ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from the United Arab Emirates.

From 2012 to 2022, the average annual rate of growth in terms of value to Tunisia amounted to +77.6%.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, which is down by -79.3% against the previous year. Over the period under review, the export price recorded a abrupt curtailment. The most prominent rate of growth was recorded in 2013 an increase of 92% against the previous year. The export price peaked at $X per ton in 2017; however, from 2018 to 2022, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for Tunisia.

From 2012 to 2022, the rate of growth in terms of prices for Oman amounted to -7.7% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into the United Arab Emirates

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported into the United Arab Emirates; increasing by 3.6% against 2021 figures. Overall, imports recorded strong growth. The pace of growth appeared the most rapid in 2019 when imports increased by 53%. Imports peaked at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports expanded significantly to $X in 2022. In general, imports showed a buoyant increase. The pace of growth was the most pronounced in 2019 when imports increased by 70% against the previous year. Over the period under review, imports reached the peak figure at $X in 2020; however, from 2021 to 2022, imports remained at a lower figure.

Imports by Country

In 2022, Germany (X tons) constituted the largest prophylactic medicaments containing insulin supplier to the United Arab Emirates, with a 32% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Germany exceeded the figures recorded by the second-largest supplier, India (X tons), threefold. Australia (X tons) ranked third in terms of total imports with a 4.7% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Germany amounted to +1.4%. The remaining supplying countries recorded the following average annual rates of imports growth: India (-6.3% per year) and Australia (+153.4% per year).

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to the United Arab Emirates, comprising 47% of total imports. The second position in the ranking was taken by India ($X), with a 2.3% share of total imports. It was followed by the United States, with a 1.6% share.

From 2012 to 2022, the average annual rate of growth in terms of value from Germany amounted to +1.5%. The remaining supplying countries recorded the following average annual rates of imports growth: India (+3.7% per year) and the United States (+30.6% per year).

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, surging by 7.3% against the previous year. In general, import price indicated a modest expansion from 2012 to 2022: its price increased at an average annual rate of +1.7% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price decreased by -15.1% against 2019 indices. The pace of growth was the most pronounced in 2013 an increase of 50%. Over the period under review, average import prices reached the maximum at $X per ton in 2015; however, from 2016 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Germany ($X per ton), while the price for Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (+10.6%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :